Navigation Links
Organization Announces End Prostate Cancer Tour
Date:6/17/2009

ZERO - The Project to End Prostate Cancer Brings Awareness Across Country;

Partnership with Depend Helps Raise Money for the Cause

WASHINGTON, June 17 /PRNewswire-USNewswire/ -- Zero prostate cancer deaths. Zero prostate cancer cases and for those with prostate cancer, it means a zero PSA. The name says it all -- zero tolerance for prostate cancer.

To kick off its summer end prostate cancer tour, ZERO is pleased to announce its partnership with Kimberly-Clark Corporation and the Depend brand. From now through 2010, proceeds from the purchase of each package of Depend Underwear for Men and Depend Guards for Men will contribute to a final donation of $250,000 to ZERO. The contribution will help to fund education for patients, free screenings for those at risk and research to discover a cure.

ZERO will tour the country this summer for a variety of events to raise awareness of the importance of early detection of prostate cancer for men at risk as part of its annual Do It for Dad program. Events will include free prostate cancer testing aboard the Drive Against Prostate Cancer on both coastlines and several states in between; a Myrtle Beach golf tournament; a Congressional Summit and a series of races during Prostate Cancer Awareness Month in September to raise awareness and funds for the cause.

ZERO -- The Project to End Prostate Cancer (ZERO) provides comprehensive treatment information to patients, education to those at risk and conducts thousands of free test
'/>"/>

SOURCE ZERO - The Project to End Prostate Cancer
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. SANYO Donates Systems Effective vs. Flu to United Nations Organization Affiliate - World Association of Former United Nations Internes and Fellows (WAFUNIF)
2. As World Health Organization Raises Influenza A (H1N1) Pandemic Alert to Level Six, Hygiene Council Recommends Simple Steps to Help Protect Families from Illness
3. World Health Organization Declares A(H1N1) Pandemic
4. Health Organizations Cheer Senate Vote on Tobacco Control
5. PIBH with NFL Star Doug Flutie Recognizes 23 PA Workers with Disabilities, 21 Organizations Supporting Those with Disabilities
6. The Physicians' Organization of the University Medical Center at Princeton Chooses iMedica's EHR and Practice Management Solutions
7. Pharmacy Organizations Brief Congress on Medication Therapy Management
8. The Physicians Organization of the University Medical Center at Princeton Chooses iMedicas EHR and Practice Management Solutions
9. Members of National CHD Organization Unite for Little Hearts Celebration and Assemble for Picture of Hope
10. Cox Business Addresses Complex Voice Needs of Health Care Organization
11. One Woman Initiative Announces First Grants to Womens Organizations in Five Nations
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Hill-Rom Announces Appointment of James R. Giertz to Board of Directors 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 2Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 3Disrupting a destructive duo 3A U of T Mississauga researchers inhibit cancer proteins 9634 1Disrupting a destructive duo 3A U of T Mississauga researchers inhibit cancer proteins 9634 2Ochsner and Rouses Markets Partner for Choose Healthy Initiative 54965 1Ochsner and Rouses Markets Partner for Choose Healthy Initiative 54965 2Ochsner and Rouses Markets Partner for Choose Healthy Initiative 54965 3Nostrils Compete to Relay Key Fragrance 54963 1Nostrils Compete to Relay Key Fragrance 54963 2